In A Nutshell A Cleveland Clinic study of nearly 8,000 adults found that patients who stopped semaglutide or tirzepatide for ...

The rapid adoption of weight-loss medications such as Ozempic, Wegovy and Zepbound represents one of the most striking cultural shifts in weight management I’ve witnessed in nearly 30 years of ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

A slow NHS rollout has so far limited wide-ranging eligibility, meaning many patients have turned to private healthcare.

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...

More people in affluent areas are using weight loss jabs, despite having lower levels of obesity, research suggests. Analysis of private prescriptions for GLP-1 drugs like Mounjaro and Wegovy shows ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...